deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT05670743

Pharmacokinetics of Advantage Arrest in Healthy Children 13-Months to 13-Years of Age

Sponsor: Advantage Silver Dental Arrest, LLC

Updated 6 times since 2023 Last updated: Aug 5, 2024 Started: Mar 1, 2023 Primary completion: Jun 10, 2023 Completion: Aug 1, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05670743, this PHASE2 trial focuses on Dental Caries in Children and remains completed. Sponsored by Advantage Silver Dental Arrest, LLC, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Aug 2023 · 4 months · monthly snapshotNot Yet Recruiting~Aug 2023 – ~Feb 2024 · 6 months · monthly snapshotActive Not Recruiting~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

    Status: Active Not RecruitingCompleted

  2. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  3. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  4. Aug 2023 — Feb 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Not Yet RecruitingActive Not Recruiting

  5. Apr 2023 — Aug 2023 [monthly]

    Not Yet Recruiting PHASE2

Show 1 earlier version
  1. Feb 2023 — Apr 2023 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Advantage Silver Dental Arrest, LLC
  • University of Washington
Data source: Advantage Silver Dental Arrest, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations